Persistent Infection with Crohn's Disease-associated Adherent-invasive Escherichia Coli Leads to Chronic Inflammation and Intestinal Fibrosis
Overview
Affiliations
Crohn's disease is a chronic inflammatory condition of the gastrointestinal tract in which alterations to the bacterial community contribute to disease. Adherent-invasive Escherichia coli are associated with human Crohn's disease; however, their role in intestinal immunopathology is unclear because of the lack of an animal model compatible with chronic timescales. Here we establish chronic adherent-invasive Escherichia coli infection in streptomycin-treated conventional mice (CD1, DBA/2, C3H, 129e and C57BL/6), enabling the study of host response and immunopathology. Adherent-invasive Escherichia coli induces an active T-helper 17 response, heightened levels of proinflammatory cytokines and fibrotic growth factors, with transmural inflammation and fibrosis. Depletion of CD8+ T cells increases caecal bacterial load, pathology and intestinal fibrosis in C57BL/6 mice, suggesting a protective role. Our findings provide evidence that chronic adherent-invasive Escherichia coli infections result in immunopathology similar to that seen in Crohn's disease. With this model, research into the host and bacterial genetics associated with adherent-invasive Escherichia coli-induced disease becomes more widely accessible.
The effect of chronic inflammation on female fertility.
Ameho S, Klustein M, Klutstein M Reproduction. 2025; 169(4).
PMID: 39932461 PMC: 11896653. DOI: 10.1530/REP-24-0197.
Multiomics reveals microbial metabolites as key actors in intestinal fibrosis in Crohn's disease.
Li X, Hu S, Shen X, Zhang R, Liu C, Xiao L EMBO Mol Med. 2024; 16(10):2427-2449.
PMID: 39271960 PMC: 11473649. DOI: 10.1038/s44321-024-00129-8.
Arroyo-Mendoza M, Proctor A, Correa-Medina A, DeWolf S, Brand M, Rosas V Nucleic Acids Res. 2024; 52(19):11552-11570.
PMID: 39258538 PMC: 11514462. DOI: 10.1093/nar/gkae773.
Leccese G, Chiara M, Dusetti I, Noviello D, Billard E, Bibi A Gut Microbes. 2024; 16(1):2380064.
PMID: 39069911 PMC: 11290758. DOI: 10.1080/19490976.2024.2380064.
Gut Microbiota Metabolites: Unveiling Their Role in Inflammatory Bowel Diseases and Fibrosis.
Bernardi F, DAmico F, Bencardino S, Faggiani I, Fanizza J, Zilli A Pharmaceuticals (Basel). 2024; 17(3).
PMID: 38543132 PMC: 10975629. DOI: 10.3390/ph17030347.